SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193805-16-002651
Filing Date
2016-02-16
Accepted
2016-02-16 16:15:06
Documents
1
Group Members
DEERFIELD INTERNATIONAL MASTER FUND, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT III, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD PRIVATE DESIGN FUND III, L.P.

Document Format Files

Seq Description Document Type Size
1 e614649_sc13g-aralez.htm SC 13G 431974
  Complete submission text file 0001193805-16-002651.txt   433484
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G

Mailing Address 1561 STEELES AVENUE EAST MILTON A6 L9T1Y1
Business Address 1561 STEELES AVENUE EAST MILTON A6 L9T1Y1 905-876-1118
Aralez Pharmaceuticals Inc. (Subject) CIK: 0001660719 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89394 | Film No.: 161428389
SIC: 2834 Pharmaceutical Preparations